Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

rogress in the pivotal phase 3 program for naproxcinod

NicOx is developing naproxcinod in phase 3 clinical studies, which are designed to demonstrate that it is safe, well tolerated and effective for treating the signs and symptoms of osteoarthritis, in addition to having no detrimental effect on blood pressure, in contrast to existing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

The phase 3 efficacy program consists of 3 pivotal studies, which are being conducted for regulatory submissions in the U.S. and Europe:

-- The 301 study was conducted in patients with osteoarthritis of the knee

and has provided successful efficacy and blood pressure results which

were presented at the American College of Rheumatology (ACR) in

November 2007. A 52-week open-label safety extension of this study has

now been completed and data are currently being analyzed

-- The 302 study started enrolling patients with osteoarthritis of the

knee in the U.S. in April 2007 and the enrollment of 1020 patients was

successfully completed in December 2007. 26-week efficacy and safety

results are anticipated in the third quarter of 2008

-- The 303 study was initiated in June 2007 in the U.S. and Europe, in

patients with osteoarthritis of the hip. This study is expected to

complete enrollment in the second quarter of 2008 and 13-week efficacy

and safety results are anticipated in 4Q'08

As in the 301 study, patients in the ongoing 302 and 303 studies are undergoing controlled, standardized Office Blood Pressure Measurements (OBPM) at each visit to the treatment center. Following the completion of the phase 3 program, NicOx plans to perform a predefined statistical analysis on the pooled OBPM data from the phase 3 studies, which should be complete in the fourth quarter of 2008. NicOx projects the submission of a New Drug Application (NDA) for naproxcinod to the U
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014 PCCA received ... ( http://bit.ly/1382OkS ) program seal for best ... The program highlights medical practices, materials and goods ... friendly." Children affected by autism often ... be exacerbated by ingredients found in food and ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "MEMS Gyroscopes ... Costing Analysis" report to their offering. ... MEMS gyroscopes for tactical grade applications made a ... in term of reliability. They are now accepted ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and ... addition of the "Inferior Vena Cava (IVC) Filters ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sector is projected to reach US$435 million by 2016. ... nearly 39% (2015) of the global value while ...
Breaking Medicine Technology:Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4
(Date:12/19/2014)... LENEXA, Kan. (PRWEB) December 19, 2014 ... dedicated exclusively to healthcare providers, has been retained to ... for Johnson Memorial Hospital in Franklin, Ind. The top ... Smith has recently placed more than 900 healthcare executives ... 100-bed, county-owned, full service hospital providing care to the ...
(Date:12/19/2014)... Pain Free Living a leader in ... a new Superior magnetic necklace using ion ... strongest neodymium magnets for the fastest pain relief in ... Superior Magnetics brand for the fastest relief by using ... therapy using Superior Magnetic Jewelry at fairs and festivals” ...
(Date:12/19/2014)... After a 13-year absence from active touring, the ... stage to entertain his many worldwide fans. Trisha Yearwood ... successful tour has been steadily expanding since the very ... Ticketability.com for a large inventory of Garth Brooks ... , Music fans have had a long wait for ...
(Date:12/19/2014)... -- Being in good shape seems to reduce your risk ... data from more than 57,000 Americans, including more than 35,000 ... and 2009. Those in the poorest shape had a ... at the start of the study, compared to a 50 ... Of the more than 8,000 people diagnosed with high blood ...
(Date:12/19/2014)... By Randy Dotinga ... (HealthDay News) -- Common painkillers, including ibuprofen, might slightly ... cancer, researchers say. Use of ibuprofen (Advil, Motrin) ... squamous cell skin cancer by 15 percent, the researchers ... cancer is usually caused by sun exposure. ...
Breaking Medicine News(10 mins):Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3
... have multiple numbers of children. A latest study done by German ... of tumors in the brain, in the older children. The ... family. ,The study was based on the data ... brain tumor patients from Sweden. The results of the study were ...
... a novel finding, researchers using brain scans have uncovered ... disorder, better known as// hysteria. The study’s findings open ... neurological disorder in which a patient complains of symptoms, ... ,The study involved three women with ...
... Patients with obstructive sleep apnea (OSA) may improve their ... new study shows that the majority of patients// with ... memory performance after 3 months of optimal CPAP use. ... on CPAP adherence. Patients who used CPAP for at ...
... to a report, San Mateo Seniors quarantine 3 more medical ... reported more this year than the// past. ,San ... outbreak, which has already sickened dozens of people in a ... ill. The doctors added that the outbreak is being ...
... achieves sharp reductions in human immunodeficiency virus (HIV) levels, ... patients with HIV infection. ,If the good ... clearly be a welcome addition to the existing treatment ... new study, led by Dr Martin Markowitz of The ...
... high-level investigation report by some of Britain's leading scientists ... to improve human health and reduce deaths// from disease. ... added. ,While speaking on the use of ... said that ‘In some cases primates are essential to ...
Cached Medicine News:Health News:Memory Improves After Sleep Apnea Therapy 2Health News:Quarantine Hits 3 More Hospitals In San Mateo 2Health News:New Drug Offers Promise as Single Treatment for HIV 2Health News:Britain Scientists Support the Use of Primates in Research 2
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
... The Vitatron Impulse II lead series ... designed to extend the longevity of ... efficient pacing. The high impedance of ... the small electrode surface, combined with ...
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
The Vitatron Excellence SS+ lead series are endocardial silicone leads providing ease of handling and optimal pacing characteristics....
Medicine Products: